Dyne Therapeutics director Jason P. Rhodes disposes of common shares worth $67.45 million
DYN•Director reports large share sales
Dyne Therapeutics director Jason P. Rhodes reported sales of 2,586,928 common shares on Aug. 13-14.
The sales were priced at $26.20 on Aug. 13 and $25.00 on Aug. 14.
Reported holdings after the transactions
Following the transactions, Rhodes' reported indirect holdings fell to 2,962 shares.
